General Atlantic's Life Science Portfolio

Pharvaris is a clinical-stage biomedical company focused on bringing oral bradykinin B2-receptor antagonists to patients.

Alumis is a precision medicine company focused on the discovery, development and treatment of autoimmune disorders.

Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.

Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, and oral kit inhibitor.

VI is the leading Enterprise-AI platform in the health sector.

Akero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state.

Biotheus is a biotech company that focuses on the discovery and development of antibody-based therapeutics.

Kalbe Genexine Biologics is developing innovative biologic therapy for high unmet medical needs in largely underserved areas.